Continuous Positive Airway Pressure or High Flow Nasal Cannula for Respiratory Distress Syndrome

Continuous Positive Airway Pressure or High Flow Nasal Cannula for Respiratory Distress Syndrome: a Randomized Control Trail among Premature Infants

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190623043988N1

Enrollment

Registered

2019-07-05

Start date

2017-01-03

Completion date

Unknown

Last updated

2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Distress Syndrome. Respiratory distress syndrome of newborn

Interventions

Intervention group: Overall, 60 preterm infants with RDS at Valiasr Hospital, Tehran, during 2018 in this randomized control trail participated as CPAP and HFNC groups’ treatment. CPAP group received

Eligibility

Sex/Gender

All

Age

1 Days to 29 Days

Inclusion criteria

Inclusion criteria: birth weight less than 2000 grams, gestational age less than 34 weeks respiratory severity between 4 to 7 score requires oxygen 60% or less

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Evaluate Continuous Positive Airway Pressure (CPAP) and High Flow Nasal Cannula (HFNC) intervention effectiveness among premature infants with RDS. Timepoint: Until the end of the breathtaking Rage. Method of measurement: evaluate Continuous Positive Airway Pressure (CPAP) and High Flow Nasal Cannula (HFNC) intervention effectiveness among premature infants with RDS.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyyed Nasrollah Hosseini

Tehran University of Medical Sciences

hosseiniseyyednasrollah@gmail.com+98 21 8804 7711

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026